Gamida Cell Stock News. The volume of gmda stock remained 0.35 million shares, which was lower than the average daily volume of 0.63 million shares within the past 50 days. The stock has traded between $3.27 and $3.65 so far today.
Gamida Cell Stock News from baobulb.org
Reports earnings results for the third quarter and nine months ended s. Private updated jan 26, 2022 10:59 pm gmda. The company's shares closed last wednesday at.
The company's shares closed last wednesday at. The volume of gmda stock remained 0.35 million shares, which was lower than the average daily volume of 0.63 million shares within the past 50 days. Rbc cuts price target on gamida cell to $11 from $14, citing setback to omidubicel fili.
The Stock Has Traded Between $3.27 And $3.65 So Far Today.
Find the latest gamida cell (nasdaqgm:gmda) stock price, news, analyst forecasts, insider trading data, and more. (gmda) stock news and headlines to help you in your trading and investing decisions. Private updated jan 26, 2022 10:59 pm gmda.
Find The Latest Gamida Cell Ltd.
Year none 2022 2021 2020 2019 2018 2017 2016. Jmp securities thinks gamida cell’s stock is going to recover. So far 824,074 shares have traded compared to average volume of 278,623 shares.
(Gmda) Stock Quote, History, News And Other Vital Information To Help You With Your Stock Trading And Investing.
Subscribe for free and invest smarter today. Gamida cell announces publication in blood, the journal of the american society of hematology, of the first pivotal trial to evaluate a cell therapy (omidubicel) for patients with blood cancer who require an allogeneic stem cell transplant read more Gamida cell announces pricing of initial public offering.
Gamida Cell Ltd (Gmda) Stock Is Trading At $3.58 As Of 1:47 Pm On Friday, Nov 12, A Rise Of $0.06, Or 1.7% From The Previous Closing Price Of $3.52.
Gmda), the penny stock, surged 22.5% to close at $2.72 on wednesday, after the company announced its plan to initiate a rolling biologics license application (bla) submission for omidubicel.the company’s plan followed the receipt of positive type b meeting correspondence from the u.s. Gamida cell announces data to be presented at 2022 transplantation & cellular therapy meetings of astct and cibmtr tandem meetings. Since then, gmda stock has decreased by 23.2% and is now trading at $3.25.
